Nicorette Inhaler Launched In First Market

15 September 1996

- Pharmacia & Upjohn has launched its new Nicorette Inhaler product for smoking cessation in Denmark, its first market. This is the first inhaled nicotine replacement product to be introduced anywhere in the world, and the Danish launch is the first of a series planned in Europe and elsewhere. P&U hopes the over-the-counter product will address some of the behavioral aspects of cigarette dependence. P&U says that its market research has found that up to 50% of smokers surveyed expressed an interest in trialling the product. Since its explosive growth and peak in the early 1990s, the nicotine replacement market has now stabilized at around $500 million a year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight